CXC Ligand 5 cytokine serum level in women with polycystic ovary syndrome and normal body mass index: A case-control study

• Main Authors: Marzieh Zohrabi, Elham Rahmani, Niloofar Motamed, Samad Akbarzadeh
• Format: Article
• Language: English
• Published: Shahid Sadoughi University of Medical Sciences 2017-12-01
• Series: International Journal of Reproductive BioMedicine
• Subjects: Polycystic ovary syndrome; Insulin resistance; CXCL5 cytokine; Hyperinsulinemia; Hyperandrogenism
• Online Access: http://journals.ssu.ac.ir/ijrmnew/browse.php?a_code=A-10-1-284&slc_lang=en&sid=1

Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disease and associated with insulin resistance. CXC Ligand 5 (CXCL5) is a new cytokine which is secreted from white adipose tissue during obesity and by blocking insulin signaling pathway inhibits the activity of insulin and promotes insulin resistance. Objective: The aim of this study was to assess serum level of CXCL5 in PCOS women with normal body mass index. Materials and Methods: In this case-control study, 30 PCOS women with normal body mass index as the case group and 30 non-PCOS women as the controls were enrolled. Serum levels of CXCL5, insulin and other hormones factors related with PCOS were measured by ELISA method, also the biochemical parameters were measured by autoanalyzer. Results: Significant increases in serum insulin concentration, homeostasis model assessments of insulin resistance, luteinizing hormone, luteinizing hormone/follicle-stimulating hormone, fasting blood sugar, testosterone, and prolactin were observed in the case group compared to the controls. were in the serum level of CXCL5, cholesterol, low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol,dehydroepiandrosterone-sulfate, creatinine, and homeostasis model assessment of beta cell function between these two groups. Conclusion: In this study, no significant change was observed in serum concentrations of CXCL5 in PCOS women with normal BMI.